Dr. Shinde, the medical director, focuses on treating patients with treatment-resistant depression and anxiety through a holistic, personalized approach, encouraging active patient involvement. His commitment to advancing psychiatric care is highlighted by his membership in the A.S.K.P and his use of ketamine therapy.
3 steps to illuminate your world
An assessment to determine if ketamine therapy is appropriate for the patient’s condition.
A personalized intravenous ketamine treatment administered in a controlled medical setting to alleviate symptoms.
Monitoring and follow-up care to assess the patient’s response and adjust future treatment plans.
This website uses cookies to ensure you get the best experience. See our Privacy Policy to learn more.